Drug profile · INN
mycobacterium bovis bcg tice strain
ONCOTICE
mycobacterium bovis bcg tice strain (ONCOTICE) is an FDA-listed pharmaceutical active ingredient. Associated with Merck KGaA, Darmstadt, Germany.
TGA: approved
Patents linked 0
Pipeline programs 9
News articles 0
Drug details — mycobacterium bovis bcg tice strain
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 9
- Data quality
- 0.81
Quick answer
mycobacterium bovis bcg tice strain (ONCOTICE) is an FDA-listed pharmaceutical active ingredient. Associated with Merck KGaA, Darmstadt, Germany.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is mycobacterium bovis bcg tice strain?
mycobacterium bovis bcg tice strain (ONCOTICE) is an FDA-listed pharmaceutical active ingredient. Associated with Merck KGaA, Darmstadt, Germany.
What is the brand name for mycobacterium bovis bcg tice strain?
ONCOTICE is a marketed brand name for mycobacterium bovis bcg tice strain. Check FDA Drugs@FDA for the current US label holder and prescribing information.